Seagen Competitors and Similar CompaniesClear all

Seagen's competitors and similar companies include Immunomedics and Metys Pharmaceuticals.
Seagen
Seagen
Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.
Immunomedics
Immunomedics
Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer.
Metys Pharmaceuticals
Metys Pharmaceuticals
Metys Pharmaceuticals is a company that provides treatment for chemotherapy-induced peripheral neuropathy, a side effect of several cancer treatments.
Founding Date
Founding Date
1998
Founding Date
1982
Founding Date
2013
Type
Type
Subsidiary
Type
Subsidiary
Type
Private
Tags
Locations
Locations
Bothell, US HQ
Mississauga, CA
Hørsholm, DK
Rueil Malmaison, FR
München, DE
Milano, IT
Schiphol, NL
see more
Locations
Morris Plains, US HQ
Locations
Basel, CH HQ
Basel, CH
Employees
Employees
3,25622% increase
Employees
1073% decrease
Employees
2
Twitter followers
Twitter followers
4.9 k
Twitter followers
568
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
$2b (FY, 2022)
Revenue (est.)
$295k (FY, 2019)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$410.1m (FY, 2022)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$1.6b (FY, 2022)
Gross profit
$295k (FY, 2019)
Gross profit
N/A
Net income
Net income
($610.3m) (FY, 2022)
Net income
($357.3m) (FY, 2019)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 164m
Total funding raised
$ 30m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Immunomedics
HQ
Morris Plains, US

Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer.

View company
Metys Pharmaceuticals
HQ
Basel, CH
Employees
2

Metys Pharmaceuticals is a company that provides treatment for chemotherapy-induced peripheral neuropathy, a side effect of several cancer treatments.

View company